PT Soho Global Health Tbk (SOHO.JK)
IDR 635.0
(0.0%)
IDR 635.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 851.38 Billion IDR | -7.82% |
| 2022 | 898.38 Billion IDR | -2.66% |
| 2021 | 922.93 Billion IDR | -17.04% |
| 2020 | 1112.51 Billion IDR | 44.53% |
| 2019 | 769.74 Billion IDR | 2.12% |
| 2018 | 753.73 Billion IDR | 3.58% |
| 2017 | 727.69 Billion IDR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 227.81 Billion IDR | -6.28% |
| 2024 Q1 | 243.06 Billion IDR | 13.97% |
| 2024 Q3 | 242.78 Billion IDR | 4.33% |
| 2023 Q2 | 205.01 Billion IDR | -13.98% |
| 2023 FY | 828.12 Billion IDR | -7.82% |
| 2023 Q4 | 213.27 Billion IDR | 2.63% |
| 2023 Q3 | 207.8 Billion IDR | 1.36% |
| 2023 Q1 | 238.34 Billion IDR | 7.41% |
| 2022 Q4 | 221.89 Billion IDR | -4.69% |
| 2022 Q3 | 232.8 Billion IDR | 5.35% |
| 2022 Q2 | 220.98 Billion IDR | -0.77% |
| 2022 Q1 | 222.69 Billion IDR | -8.02% |
| 2022 FY | 898.38 Billion IDR | -2.66% |
| 2021 Q2 | 223.15 Billion IDR | 5.58% |
| 2021 Q3 | 246.31 Billion IDR | 10.38% |
| 2021 Q1 | 211.35 Billion IDR | -28.73% |
| 2021 FY | 922.93 Billion IDR | -17.04% |
| 2021 Q4 | 242.11 Billion IDR | -1.7% |
| 2020 Q2 | 220.03 Billion IDR | 8.45% |
| 2020 Q4 | 296.56 Billion IDR | -15.78% |
| 2020 Q3 | 352.12 Billion IDR | 60.03% |
| 2020 Q1 | 202.9 Billion IDR | 23.33% |
| 2020 FY | 1112.51 Billion IDR | 44.53% |
| 2019 Q4 | 164.52 Billion IDR | 0.0% |
| 2019 Q1 | 173.73 Billion IDR | 0.0% |
| 2019 FY | 769.74 Billion IDR | 2.12% |
| 2018 FY | 753.73 Billion IDR | 3.58% |
| 2017 FY | 727.69 Billion IDR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 1992.05 Billion IDR | 57.261% |
| PT Itama Ranoraya Tbk | 100.18 Billion IDR | -749.802% |
| PT Kimia Farma (Persero) Tbk | 4350.51 Billion IDR | 80.43% |
| PT Millennium Pharmacon International Tbk | 184.42 Billion IDR | -361.652% |